To examine how the inclusion (+) or exclusion (-) of inactivated Leptospira antigens in a vaccine for canine parvovirus type 2 (CPV-2), canine distemper virus (CDV) and canine adenovirus type 2 (CAdV-2) affects antibody titres to CPV-2, CDV and CAdV-1 antigens, household dogs were vaccinated with commercially available vaccines from one of three manufacturers. CPV-2, CDV and CAdV-1 antibody titres were measured 11 to 13 months later and compared within three different age groups and three different bodyweight groups. There were significant differences between CPV-2 antibody titres in dogs vaccinated with (+) vaccine and those vaccinated with (-) vaccine for two products in the two-year-old group and for one product in the greater than seven-year-old group; no significant differences were seen that could be attributed to bodyweight. No differences in CDV antibody titres were observed within age groups, but a significant difference was seen in the 11 to 20 kg weight group for one product. Significant differences in CAdV-1 antibody titres were seen for one product in both the two-year-old group and the ≤10 kg weight group.
the America-1 lineage, but in recent years, there have been reports of canine distemper in vaccinated dogs (Ek-Kommonen and others 1997), for which differences in the antigenicity of field strains and vaccine strains have been indicated (Iwatsuki and others 2000, Lan and others 2006) .
Infectious canine hepatitis (ICH) is a disease caused by canine adenovirus type 1 (CAdV-1) (Emery and others 1978) , but inoculation with a live attenuated CAdV-1 vaccine is known to lead to interstitial nephritis and corneal opacity (Appel and others 1973) , and encephalitis is known to occur with coadministration with CDV (Cornwell and others 1988) . CAdV-2 is a pathogen causing infectious tracheo bronchitis (ITB) and is related antigenically to CAdV-1, and cross-protection has been confirmed between CAdV-1 and CAdV-2 (Appel and others 1973) . Therefore, an attenuated CAdV-2 vaccine is used for prevention of ICH others 1973, Decaro and others 2008) .
Leptospira is a Gram-negative bacillus that infects dogs and wild rodents, such as mice. Leptospira can also inhabit bodies of water such as rivers and marshes, allowing for possible infection of dogs from the environment (Greene and others 2006) . In addition, several different serotypes of Leptospira are known to exist so vaccination must target the relevant serotypes (Stokes and others 2007) .
The most common vaccines for these diseases consist of viral antigens combined to produce an inactivated vaccine; however, investigations into the influence of including Leptospira antigen on viral antibody production have not yet become available. The aim of this study was to investigate the effect of vaccinating dogs with commercially available combination vaccines, with or without Leptospira, on CPV-2, CDV and CAdV-1 antibody titres measured a year later, and to compare antibody levels within groups on the basis of age or bodyweight.
Materials and methods

Vaccines
Six vaccines that are commercially available in Japan were used. These were given the labels A (Nobivac; Intervet International), B (Eurican; Merial Japan) and C (Vanguard; Pfizer Japan). Combination vaccines A(-) and B(-) contain CPV-2, CDV, CAdV-2 and canine parainfluenza virus (CPiV), and vaccine C(-) contains canine coronavirus and adjuvant in addition to the above. Vaccines A(+), B(+) and C(+) are the same as A(-), B(-) and C(-), respectively, but with inactivated vaccines for Leptospira Icterohaemorrhagiae and Leptospira Canicola. The origin of CPV-2 in A(-) and A(+) is the attenuated CPV 154 strain with a TCID 50 of ≥10 7.0 . In B(-) and (+), its origin is CPV-115-780916 strain with a TCID 50 of ≥10 4.9 and in C(-) and (+) it comes from CPV NL-35D-LP strain with a TCID 50 of ≥10 6.4 . The origin of CDV is the Onderstepoort strain with a TCID 50 of ≥10 4.0 in A(-) and (+) and B(-) and (+), and the Snyder Hill strain with a TCID 50 of ≥10 3.5 in C(-) and (+). The origin of CAdV-2 is the Manhattan strain in all vaccines, with a TCID 50 of ≥10 4.0 in A(-) and (+), ≥10 3.0 in B(-) and (+) and ≥10
5.5
in C(-) and (+). The origin of Leptospira is the L Icterohaemorrhagiae 820K strain ≥1 x 10 9 cells and L Canicola Ca-12-000 strain ≥1 x 10 9 cells in A(+), the L Icterohaemorrhagiae LI 84 strain 146 NTU and L Canicola LC87 K1 strain 130 NTU in B(+) and the L Icterohaemorrhagiae NADL11403 strain 600 NTU and L Canicola C-51 strain 600 NTU in C(+).
Dogs
A total of 961 adult household dogs aged from two to 16 years, including 399 sexually intact males, 101 neutered males, 241 sexually intact females and 220 neutered females, were examined. Dogs were divided into three age groups (two years old, three to six years old or seven years old or above) and three bodyweight groups (1 to 10 kg, 11 to 20 kg or 21 kg or more).
Serological tests
Serum samples were collected from dogs that had received combination vaccines that either contained or did not contain Leptospira bacterin 12 months (± one month) before collection. These samples were sent frozen to a commercial veterinary diagnostic laboratory (Marupi Lifetech) for measurement of serum antibody titres. CPV-2 antibody titres were obtained using the haemagglutination inhibition (HI) test, CDV antibody titres were measured using the immune peroxidase (IP) test and CAV-1 antibody titres were measured using the neutralisation test (NT).
Statistical analysis
To investigate the distribution of CPV-2, CDV and CAV-1 antibody titres between each product with or without Leptospira, a box and whisker plot was made. To investigate the differences in antibody titre by age and bodyweight, comparisons between the reciprocal of the dilution of antibody titre were calculated using the MannWhitney U test (Bergman and others 2006) and were made by a logistical method in the JMP software system. In all tests, P<0.05 was considered to indicate a significant difference.
Results
A box and whisker plot of CPV-2, CDV and CAdV-1 antibody titre distributions and mean titres by product is shown in Fig 1. The mean values of CPV-2, CDV and CAdV-1 antibody titres varied significantly between the products.
Analysis by age group suggested that inclusion of Leptospira was associated with a reduced CPV-2 antibody titre in the two-year-old group for products A and C (Table 1 ). There were no significant differences between (+) and (-) vaccines in the three-to six-year-old group; however, use of the C(+) vaccine resulted in a lower CPV-2 antibody titre in dogs aged seven years and older, compared with the use of C(-) vaccine. In all age groups examined, there were no significant differences in CDV antibody titre between dogs receiving a vaccine containing Leptospira and those receiving a vaccine not containing Leptospira. The mean CAdV-1 antibody titre in two-yearold dogs was significantly lower in dogs receiving the C(+) vaccine compared with dogs receiving the C(-) vaccine.
On analysis by bodyweight (Table 2) , there were no differences in CPV-2 antibody titre due to the inclusion of Leptospira for all weight groups, but inclusion of Leptospira in product C resulted in lower CDV antibody titres in dogs weighing 11 to 20 kg. CAdV-1 antibody titres were also lower in dogs weighing 11 to 20 kg that received the C(+) vaccine, compared with the C(-) vaccine.
Discussion
Because acute cases of canine parvovirus infection, canine distemper and ICH can be fatal, vaccines against these diseases should be con- sidered core vaccines for dogs. It is also necessary to vaccinate dogs that are at risk of exposure to Leptospira. As Leptospira is maintained in wild rodents and inhabits marshy areas, the differential use of combination vaccines containing only viral antigens and vaccines also containing Leptospira bacterin should depend on whether the dog is likely to encounter Leptospira in the environment (Greene and Appel 2006) . According to each manufacturer's technical information, inoculation with these vaccines results in an antibody titre sufficient to withstand challenge infection. However, these numbers are based on the results of an experimental challenge infection using dogs of a specific age and with specific physical attributes. Reports using clinical cases have indicated that CPV, CDV and CAdV antibody titres are influenced by age (Twark and Dodds 2000 , Böhm and others 2004 , McCaw and Hoskins 2006 , Ottiger and others 2006 . In addition, Kennedy and others (2007) reported that physical attributes influenced antibody titres resulting from rabies vaccination. On the basis of these previous reports, the present study investigated viral antibody titres following vaccination with or without inactivated Leptospira in dogs divided into groups based on their ages and physical attributes.
Inclusion of Leptospira resulted in lower CPV-2 antibody titres in the two-year-old and seven-year-old or above age groups, and lower CAdV-1 antibody titres in the two-year-old group. Among groups divided by bodyweight, inclusion of Leptospira resulted in lower CDV and CAdV-1 titres in dogs weighing 11 to 20 kg. The effect of Leptospira inclusion on the antibody titre for CPV-2 was unrelated to bodyweight but varied in some cases due to age, whereas CDV titres were unrelated to age but varied in some cases due to bodyweight. Inclusion of Leptospira affected CAdV-1 titres in some cases, depending on both age and bodyweight.
Interference effects between viruses in combination vaccines include reports of CDV inhibiting CPV replication in Crandell feline kidney cells simultaneously inoculated with CPV and CDV (Gemma and others 1995) . However, the mechanisms responsible for this are not well understood.
The present study compared antibody titres following vaccination with three different products with three viral strains, targeting three different age groups, giving 27 different combinations for testing; a further 27 combinations arose from the investigation of the effect of bodyweight. Of these 54 combinations, significant differences were seen in five cases, accounting for less than 10 per cent of the total. However, in all of these cases, inclusion of Leptospira resulted in lower antibody titres in vaccinated dogs, indicating the possibility of interference effects from Leptospira bacterin on viral activity.
When inoculating with an inactivated vaccine for Leptospira, separate inoculation with a vaccine containing only viral antigens is a more reliable method of obtaining higher CPV-2, CDV and CAdV-1 antibody titres. 
